KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Interest Coverage Ratio (2019 - 2025)

Esperion Therapeutics (ESPR) has disclosed Interest Coverage Ratio for 7 consecutive years, with 3.77 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 1498.98% year-over-year to 3.77, compared with a TTM value of 0.71 through Dec 2025, down 22.41%, and an annual FY2025 reading of 0.71, down 22.41% over the prior year.
  • Interest Coverage Ratio was 3.77 for Q4 2025 at Esperion Therapeutics, up from 0.45 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 5.15 in Q1 2024 and bottomed at 10.19 in Q1 2021.
  • Average Interest Coverage Ratio over 5 years is 1.9, with a median of 2.68 recorded in 2023.
  • Peak annual rise in Interest Coverage Ratio hit 1498.98% in 2025, while the deepest fall reached 122.07% in 2025.
  • Year by year, Interest Coverage Ratio stood at 4.14 in 2021, then increased by 28.37% to 2.97 in 2022, then grew by 5.16% to 2.81 in 2023, then surged by 90.43% to 0.27 in 2024, then skyrocketed by 1498.98% to 3.77 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ESPR at 3.77 in Q4 2025, 0.45 in Q3 2025, and 0.35 in Q2 2025.